The latest international news, analysis and features on the HIV epidemic from Avert. Share your views and expertise with your peers in the comments box below the articles.
Significant step as WHO recommends the dapivirine vaginal ring as a new HIV prevention tool following promising trial results
Global evidence review finds wide variation on STI testing, despite people on PrEP being at greater risk of sexually transmitted infections.
More than 10% of men who have sex with men, sex workers and prisoners with HIV have drug resistance when beginning treatment
Review initially finds dolutegravir has no links to birth defects then revises its findings to report a ‘slightly higher’ – but minimal – incidence after two cases emerge
Global survey finds a high proportion of people living with HIV know that ‘Undetectable = Untransmittable’ – and are more likely to be healthy compared to those who are unaware.
New 2025 targets aim to put the world back on track to end AIDS by 2030 following the news that Fast-Track targets were missed.
Trial reports a 15% difference in high PrEP adherence among participants who received vouchers compared to those who didn’t – but this fell significantly after the vouchers stopped.
Sexual health is about so much more than infection prevention – it’s about being happy with yourself and in your sex life. Help us to spread the word that everyone has a right to pleasurable and safer sex!
Women who sell sex are experiencing high levels of mental health issues, reveals a groundbreaking evidence review.
The first evidence review to focus on men who buy sex – rather than women who sell it – finds a strong association between purchasing sex and HIV.
Ring containing the antiretroviral drug dapivirine could be available in Africa as early as 2021 after it was found to reduce women’s HIV risk by 30 to 50%.